POLE and endometrial cancer: Leon-Castrillo et al., from Leiden University, reviewed and summarized all available data, identifying 11 pathogenic somatic missense mutations (Table 1) within the POLE exonuclease domains that classify as POLEmut endometrial cancer [55].